Progress made on recommendations for making clinical cancer research more effective and efficient
A 2009 update recently has been released summarizing the latest progress in implementing recommendations that were agreed upon during the Brookings Conference on Clinical Cancer Research in September 2008.
The conference was hosted last fall by the Engelberg Center for Health Care Reform at the Brookings Institute, in collaboration with AACR, Friends of Cancer Research (Friends) and the American Society for Clinical Oncology (ASCO). Key stakeholders met to discuss critical scientific and regulatory challenges as well as opportunities for accelerating innovations in cancer therapy. Four panels of experts came together to discuss recommendations to specifically address challenges of data submission standards and evidence requirements, efficacy endpoints, co-development of diagnostics and therapeutics, and a vision for the future of Food and Drug Administration (FDA).
The 2009 update reviews the actions that have been taken to advance panel recommendations for the benefit of improving clinical cancer research.
In the News:
Read More from the March Edition of the AACR Cancer Policy Monitor: